Effect of Pharmacist Intervention on Urinary Tract Infection Prognosis: A Multicentre, Randomized Clinical Trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
INTERVENTION: Control Group:Medical Care Management;Intervention Group:Clinical Pharmacist Intervention Group; CONDITION: Urinary tract stone PRIMARY OUTCOME: The incidence of sepsis; SECONDARY OUTCOME: Antibacterial drug DDDs;The incidence rate of SIRS after surgery;length of stay; INCLUSION CRITERIA: 1. Age 18 years or older; 2. Diagnosed with upper urinary tract stones (kidney stones; ureteral stones); 3. Admitted to the urology department for minimally invasive surgery for upper urinary tract stones; 4. Able to understand and provide the ability to sign an informed consent form;
Epistemonikos ID: 4edb29fa14e1f2c6b74f4cd300c963236396f11d
First added on: Jul 25, 2026